{"news_desk": "Science", "print_page": "7", "subsection_name": null, "section_name": "Health", "byline": {"original": "By KATIE THOMAS", "person": [{"firstname": "Katie", "rank": 1, "lastname": "THOMAS", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "1534", "keywords": [{"rank": "1", "value": "Trump, Donald J", "is_major": "N", "name": "persons"}, {"rank": "2", "value": "Food and Drug Administration", "is_major": "N", "name": "organizations"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Regulation and Deregulation of Industry", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Food", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Medical Devices", "is_major": "N", "name": "subject"}, {"rank": "7", "value": "Gottlieb, Scott (1972- )", "is_major": "N", "name": "persons"}, {"rank": "8", "value": "O'Neill, Jim (1968- )", "is_major": "N", "name": "persons"}, {"rank": "9", "value": "Gulfo, Joseph V", "is_major": "N", "name": "persons"}], "lead_paragraph": "A top candidate to head the agency, Jim O\u2019Neill, advocates \u201cprogressive\u201d approval, in which drugs proved safe could be sold to consumers even if not yet proved effective.", "pub_date": "2017-02-05T17:12:37+0000", "document_type": "article", "source": "The New York Times", "snippet": "A top candidate to head the agency, Jim O\u2019Neill, advocates \u201cprogressive\u201d approval, in which drugs proved safe could be sold to consumers even if not yet proved effective....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2017/02/06/us/06fda-web01/06fda-web01-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2017/02/06/us/06fda-web01/06fda-web01-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2017/02/06/us/06fda-web01/06fda-web01-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2017/02/06/us/06fda-web01/06fda-web01-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2017/02/06/us/06fda-web01/06fda-web01-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2017/02/06/us/06fda-web01/06fda-web01-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2017/02/05/health/with-fda-vacancy-trump-sees-chance-to-speed-drugs-to-the-market.html", "slideshow_credits": null, "blog": [], "_id": "58975d0d7c459f2525d1a910", "headline": {"main": "Trump\u2019s F.D.A. Pick Could Undo Decades of Drug Safeguards", "print_headline": "Decades of Policies Could Fall at F.D.A."}}